Christoph Meisner

Tuebingen, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.

Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 16, 2025

Correction: A systematic review of the etiopathogenesis of Kienböck's disease and a critical appraisal of its recognition as an occupational disease related to hand-arm vibration.

Correction: A systematic review of the etiopathogenesis of Kienböck's disease and a critical appraisal of its recognition as an occupational disease related to hand-arm vibration.

Journal: BMC musculoskeletal disorders

Published: March 14, 2024

High-Dose Glucocorticoids for the Treatment of Sudden Hearing Loss.

High-Dose Glucocorticoids for the Treatment of Sudden Hearing Loss.

Journal: NEJM evidence

Published: February 06, 2024

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: August 28, 2023

Hypnotherapy and cognitive-behavioral therapy for depression - Results from the three and a half year follow-up of a randomized controlled non-inferiority study

Hypnotherapy and cognitive-behavioral therapy for depression - Results from the three and a half year follow-up of a randomized controlled non-inferiority study

Journal: Psychotherapie, Psychosomatik, medizinische Psychologie

Published: July 24, 2023

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.

Journal: Nature communications

Published: June 14, 2023

Long-Term Outcomes of Depression Treatment With Hypnotherapy or Cognitive Behavioral Therapy.

Long-Term Outcomes of Depression Treatment With Hypnotherapy or Cognitive Behavioral Therapy.

Journal: The Journal of nervous and mental disease

Published: March 17, 2023

Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group.

Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group.

Journal: Cancers

Published: February 01, 2023

Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Tocilizumab for the Treatment of Familial Mediterranean Fever-A Randomized, Double-Blind, Placebo-Controlled Phase II Study.

Journal: Journal of clinical medicine

Published: August 01, 2022

Intratympanic corticosteroids for sudden sensorineural hearing loss.

Intratympanic corticosteroids for sudden sensorineural hearing loss.

Journal: The Cochrane database of systematic reviews

Published: July 22, 2022

Impact of the SARS-CoV-2 Pandemic on Liver Surgery and Liver Transplantations in Germany

Impact of the SARS-CoV-2 Pandemic on Liver Surgery and Liver Transplantations in Germany

Journal: Zentralblatt fur Chirurgie

Published: July 21, 2022

Efficacy and safety of systemic, high-dose glucocorticoid therapy for idiopathic sudden sensorineural hearing loss : Study protocol for a three-armed, randomized, triple-blind, multicenter trial (HODOKORT).

Efficacy and safety of systemic, high-dose glucocorticoid therapy for idiopathic sudden sensorineural hearing loss : Study protocol for a three-armed, randomized, triple-blind, multicenter trial (HODOKORT).

Journal: HNO

Published: May 09, 2022

Showing 1-12 of 84

Last Updated: 09/26/2026